Gastrointestinal Stromal Tumors

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)

Completed
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +34 more
Nov 17, 2022

Gastrointestinal Stromal Tumors Trial in Japan, United States (DS-6157a)

Completed
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +4 more
Apr 7, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +3 more
  • La Jolla, California
  • +4 more
Aug 17, 2021

Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
  • +5 more
Apr 30, 2021

Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Scottsdale, Arizona
  • +25 more
Apr 16, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)

Completed
  • Gastrointestinal Stromal Tumors
  • Regorafenib (Stivarga, BAY73-4506)
  • +2 more
  • Scottsdale, Arizona
  • +56 more
Jan 27, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Sunitinib)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +120 more
Jan 4, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Gastrointestinal Stromal Tumors Trial in Czechia, France, United States (sunitinib malate dose escalation, sunitinib malate)

Completed
  • Gastrointestinal Stromal Tumors
  • sunitinib malate dose escalation
  • sunitinib malate
  • Los Angeles, California
  • +8 more
Mar 1, 2019

Gastrointestinal Stromal Tumors Trial in United States (Imatinib mesylate)

Terminated
  • Gastrointestinal Stromal Tumors
  • Imatinib mesylate
  • Los Angeles, California
  • +12 more
Aug 22, 2013

Gastrointestinal Stromal Tumors, Gastrointestinal Tumors Trial in Los Angeles, Park Ridge, Boston (XL820)

Completed
  • Gastrointestinal Stromal Tumors
  • Gastrointestinal Neoplasms
  • Los Angeles, California
  • +2 more
May 30, 2013

Gastrointestinal Stromal Tumors Trial in France, Italy, United States (Nilotinib, Imatinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib, Imatinib
  • Boston, Massachusetts
  • +3 more
May 9, 2013

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Best Supportive Care (BSC) +/- imatinib or sunitinib
  • Los Angeles, California
  • +34 more
Jun 5, 2012

Gastrointestinal Stromal Tumors, Soft Tissue Sarcomas Trial in Canada, United States (IPI-504)

Completed
  • Gastrointestinal Stromal Tumors
  • Soft Tissue Sarcomas
  • Scottsdale, Arizona
  • +4 more
Jan 5, 2011

Gastrointestinal Stromal Tumors Trial in France, Italy, United States (SU011248)

Completed
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +3 more
Sep 9, 2009